Luisa Weiss

7PUBLICATIONS
16CO-AUTHORS
Medical biochemistry - proteins and peptides (incl. medical proteomics)Respiratory diseasesCardiology (incl. cardiovascular diseases)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Mar 25, 2026
Impact of Variations in Commercial Standard Operating Procedure on Plasma Proteome Recovery.

Taku Kasai, Luisa Weiss, Jessica Wohlfahrt

|Jan 09, 2024
Proteomic analysis of extracellular vesicle cargoes mirror the cardioprotective effects of rivaroxaban in patients with venous thromboembolism.

|Feb 01, 2022
Non-severe COVID-19 is associated with endothelial damage and hypercoagulability despite pharmacological thromboprophylaxis.

Sarah Kelliher, Luisa Weiss, Sarah Cullivan

|Jun 23, 2021
Nonvalvular atrial fibrillation patients anticoagulated with rivaroxaban compared with warfarin exhibit reduced circulating extracellular vesicles with attenuated pro-inflammatory protein signatures.

Luisa Weiss, John Keaney, Paulina B Szklanna

|Feb 17, 2021
COVID-19 induces a hyperactive phenotype in circulating platelets.

Shane P Comer, Sarah Cullivan, Paulina B Szklanna

Pageof 2

Frequent Collaborators

3 joint publications

Shane P Comer

3 joint publications

Patricia Maguire

3 joint publications

Fionnuala Ní Áinle

2 joint publications

Sarah Kelliher